Compare Intel Corp (INTC) vs McKesson Corporation (MCK) Price & Performance

Intel CorpTrade

McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

Intel Corp vs McKesson Corporation — how do they compare? Intel Corp trades at $99.73 (market cap $492.85B), while McKesson Corporation trades at $898 (market cap $105.14B). The key difference: Intel Corp is far larger — about 4.7× McKesson Corporation's market cap, and Intel Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.

	INTC	MCK
Market Cap	$492.85B	$105.14B
Volume	43,552,012	—
Sector	Technology	Health
52-Week High	$140.94	$995.69
52-Week Low	$21.81	$659.01
Enterprise Value	$513.66B	$111.67B
Dividend Yield	2.24%	0.42%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INTC

Polen 5Perspectives Large Growth Portfolio outperforms Russell 1000 Growth with 26.63% return in Q2 2026Seeking Alpha · 13 hours agoBullish Intel stock upgraded to Buy as Q2 revenue jumps 25%, margins expand, and outlook beats expectations.Seeking Alpha · 1 day agoBullish Intel stock soars 370% in a year, fueled by Nvidia partnership and AI demand.Finbold · 1 day agoBullish View details →

MCK

View details →

About Intel Corp

Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.